Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 45% ± 17% | |
GABAergic neuron | 3 studies | 41% ± 7% | |
neuron | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2093.40 | 1445 / 1445 | 100% | 25.26 | 183 / 183 |
lung | 100% | 2332.33 | 578 / 578 | 100% | 25.02 | 1155 / 1155 |
ovary | 100% | 2463.78 | 180 / 180 | 100% | 29.07 | 430 / 430 |
breast | 100% | 2456.73 | 459 / 459 | 100% | 43.73 | 1116 / 1118 |
brain | 100% | 3183.90 | 2639 / 2642 | 100% | 34.74 | 704 / 705 |
adrenal gland | 100% | 2064.02 | 258 / 258 | 100% | 30.17 | 229 / 230 |
bladder | 100% | 2324.76 | 21 / 21 | 99% | 22.35 | 501 / 504 |
stomach | 100% | 1695.65 | 359 / 359 | 99% | 18.75 | 284 / 286 |
skin | 100% | 1990.89 | 1809 / 1809 | 99% | 25.34 | 468 / 472 |
intestine | 100% | 2171.39 | 966 / 966 | 99% | 17.10 | 522 / 527 |
prostate | 100% | 2575.16 | 245 / 245 | 99% | 19.25 | 496 / 502 |
thymus | 100% | 2435.34 | 653 / 653 | 99% | 23.73 | 597 / 605 |
kidney | 100% | 1920.31 | 89 / 89 | 98% | 19.78 | 886 / 901 |
uterus | 100% | 2730.86 | 170 / 170 | 98% | 23.55 | 449 / 459 |
pancreas | 98% | 1101.51 | 322 / 328 | 98% | 19.88 | 175 / 178 |
liver | 91% | 640.23 | 206 / 226 | 69% | 7.85 | 280 / 406 |
adipose | 100% | 2505.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2582.93 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2017.09 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2139.76 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.01 | 1 / 1 |
heart | 99% | 1691.84 | 855 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 17.40 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 91% | 13.18 | 73 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 12.04 | 25 / 29 |
peripheral blood | 79% | 674.29 | 730 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0019902 | Molecular function | phosphatase binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
Gene name | CSRNP2 |
Protein name | Cysteine/serine-rich nuclear protein 2 (CSRNP-2) (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12) (TAIP-12) Cysteine and serine rich nuclear protein 2 |
Synonyms | C12orf22 TAIP12 FAM130A1 |
Description | FUNCTION: Binds to the consensus sequence 5'-AGAGTG-3' and has transcriptional activator activity (By similarity). May play a role in apoptosis. . |
Accessions | F8W1G8 F8VVN1 Q9H175 F8VTU0 F8VZY2 ENST00000546935.5 ENST00000552899.5 ENST00000548981.5 ENST00000548206.1 ENST00000228515.6 |